FDA Panel Votes 21-16 To Recommend Lowering Maximum Daily Dosage of Johnson & Johnson's (JNJ) Tylenol
More News related to JNJ
- Trading Outlook for Advanced Life Sciences Holdings Inc. Issued by InvestorSoup.com
- Johnson & Johnson (JNJ) Sets Massive Restructuring, Cutting Up to 8,000 Jobs
- J&J (JNJ) Announces Restructuring Initiatives: to 6-7% of Global Workforce, Sees Pre-Tax Savings of $1.4-$1.7B in '11
- Johnson & Johnson (JNJ) to cut 6-7% of global workforce
- Johnson & Johnson Announces Restructuring Initiatives for Sustainable Growth
FDA Panel Votes 21-11 to recommend switch Johnson & Johnson (NYSE: JNJ) max dose of Tylenol to prescription only.
FDA Panel Votes 24-13 To Recommend limiting single dosage to 650mg
FDA Panel Votes 21-16 to recommend lower maximum daily dosage of Tylenol
Related Categories
FDAHot List
Stocks Mentioned
+0.32Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
